Biogen
BIIB
#617
Rank
$31.94 B
Marketcap
$219.39
Share price
2.32%
Change (1 day)
-26.54%
Change (1 year)

Biogen is an American biotech company based in Cambridge, Massachusetts. The company uses recombinant DNA technology, also known as biotechnology. This makes it possible to produce human proteins and therefore medicinal products with the help of microorganisms. The company continues to develop new substances and works on improving already approved molecules.

Biogen (BIIB) - Total debt

Total debt on the balance sheet as of March 2024 : $6.94 B

According to Biogen's latest financial reports the company's total debt is $6.94 B. A companyโ€™s total debt is the sum of all current and non-current debts.

Biogen - Total debt on balance sheet (from 2001 to 2024)

Total debt by year

Year Total debt Change
2023-12-31$7.33 B10.95%
2022-12-31$6.61 B-13.01%
2021-12-31$7.60 B-2.87%
2020-12-31$7.82 B22.94%
2019-12-31$6.36 B7.26%
2018-12-31$5.93 B-0.03%
2017-12-31$5.93 B-8.89%
2016-12-31$6.51 B-0.14%
2015-12-31$6.52 B1018.67%
2014-12-31$0.58 B-2.1%
2013-12-31$0.59 B-47.77%
2012-12-31$1.14 B7.21%
2011-12-31$1.06 B-11.59%
2010-12-31$1.20 B9.42%
2009-12-31$1.09 B-1.18%
2008-12-31$1.11 B-28.78%
2007-12-31$1.56 B1516.42%
2006-12-31$96.69 M122.57%
2005-12-31$43.44 M-94.89%
2004-12-31$0.85 B-4.17%
2003-12-31$0.88 B2.43%
2002-12-31$0.86 B1735.76%
2001-12-31$47.18 M

Total debt for similar companies or competitors

Company Total debt differencediff. Country
$33.63 B 384.15%๐Ÿ‡บ๐Ÿ‡ธ USA
$68.70 B 889.09%๐Ÿ‡บ๐Ÿ‡ธ USA
$74.00 B 965.28%๐Ÿ‡บ๐Ÿ‡ธ USA
$64.02 B 821.60%๐Ÿ‡บ๐Ÿ‡ธ USA
$20.36 B 193.20%๐Ÿ‡ซ๐Ÿ‡ท France
$25.19 B 262.68%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.27 B-67.24%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.19 B-97.18%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.50 B-78.36%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
$1.39 B-79.85%๐Ÿ‡บ๐Ÿ‡ธ USA